You searched for "AMD"
How to survive the fluorescein round
1 December 2016
| Gwyn Samuel Williams
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Pathology, EYE - Paediatrics, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
One of the highlights of the medical retina fellowship programme at Moorfields is the Tuesday morning 8am fluorescein round. It is both exhilarating and terrifying. Exhilarating because they are slick presentations of the most interesting cases that each of the...
Safety and efficacy of a nurse-led intravitreal injection service using an Precivia® injection assist device
1 December 2021
| Ibrar Ahmed, Panayiotis Maghsoudlou, Hani Hasan, Allaaeldin Abumattar, Nimish Shah
|
EYE - Vitreo-Retinal, EYE - General
Nurse-led intravitreal injections have become of great importance for busy eye units. In this article, the authors present safety data from five years of a nurse-led service with the use of the Precivia® intravitreal injection assist device. Intravitreal injections of...
Patient and public participation shapes biomedical research and access priorities in eye health
1 December 2014
| Rod McNeil
|
EYE - General
Patients, clinicians and clinician-scientists play a valuable role in shaping the future of vision research. Limited funding demands targeted research initiatives that ultimately will shape health policy and practice to secure progress in improving patient outcomes in eye health. This...
What's trending Oct/Nov 2019
#probeyeotic #eyeballbugs #microbiome The human microbiome usually conjures up images of the gastrointestinal tract and yoghurt containing good bacteria. However, research suggests that the ocular mucosa is home to a unique microbe collection, with important immunological functional properties [1]. This...
Detecting apoptosis in retinal cells
1 February 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Apoptosis, Glaucoma, Imaging, Neurodegeneration, Retina
This is a review paper in which the authors summarise the transitioning of techniques detecting apoptosis from bench to bedside, along with the future possibilities they encase. Detection of Apoptosis in Retinal Cells (DARC) technology can be used as a...
Licence to save: a UK survey of anti-VEGF use for the eye
1 February 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
WATCH EPISODE 6: Beyond 2020 with the Andean Medical Mission
Welcome to the sixth episode of Beyond 2020, the series that looks at strategies to eliminate avoidable blindness in countries with developing eyecare services and shares ideas and solutions to common difficulties in working abroad.The meaning of life
Supercomputer: “The answer to the great question of Life, the Universe and Everything is…”Programmer: “Yes…?”Supercomputer: “42. It was a tough assignment”.Programmer: “42? Is that all you have got to show for seven and a half million years work?” In this...A glossary
5 October 2020
| Gwyn Samuel Williams
|
EYE - General
After a week on call grading what feels like 13 billion referrals I decided it might be useful to come up with a glossary that might help other people in some way to decipher the true meaning behind every repetitive...
Prostaglandin levels in femto cataract surgery
Following previous reports of pupil size decrease after femtosecond treatment, the authors compare levels of prostaglandins in patients undergoing femtosecond assisted cataract surgery with those having routine cataract surgery. Patients with inflammatory eye disease, previous trauma surgery, age-related macular degeneration...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Treat-and-extend regimen in treatment of patients with type 3 neovascularisation
5 October 2020
| Su Young
|
EYE - Vitreo-Retinal
Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...
